Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Jury finds PeaceHealth, ER doctor not liable for misdiagnosing patient’s stroke
After a three week trial, a jury found that PeaceHealth and Ralph Weiche, MD, acted in accordance with medical protocols in diagnosing Patricia Parker with a psychiatric condition, given her unusual symptoms.
Women less likely to receive DCD heart transplants
Donation after circulatory death heart transplants are gaining popularity in the United States, but men are much more likely to be selected for one.
Mayo Clinic develops AI capable of substantially improving dementia diagnoses
With the software's help, readers are up to three times more accurate and interpretations are nearly twice as fast.
Private equity firm jumps into vascular health with new investment
Vascular Technology, first founded 40 years ago, is planning on using the new funds to grow and expand its portfolio.
At a crossroads: Surgical heart valve innovation slows as transcatheter treatments keep evolving
Has the success of TAVR and other interventional techniques had a negative impact on surgical valve innovation? Two surgeons shared their concerns in a new commentary.

The team that implanted the first TaurusTrio TAVR valve at Beijing An Zhen Hospital, Capital Medical University in July 2023.

Chinese made version of JenaValve TAVR device implanted in first patient

The first patient was enrolled in a multicenter clinical trial for the TaurusTrio transcatheter aortic valve replacement system, used for aortic regurgitation.

Abbott pulled the Trifecta GTaortic surgical valve off market in July 2023 after it was determined it had early structural valve deterioration (SVD) before 5 years.

Abbott pulls Trifecta heart valves off the market due to early deterioration

The FDA sent notice today that Abbott is pulling the Trifecta aortic surgical heart valve off the U.S. market due to the risk of early structural valve deterioration in less than 5 years.

How depression, cognitive dysfunction impact long-term TAVR outcomes

Both conditions are fairly common in patients who undergo TAVR. Is this something cardiologists should be keeping in mind?

GE Healthcare recall TruSignal SpO2 sensors

GE Healthcare recalls certain SpO2 sensors due to risk of serious errors during defibrillation

There is a risk of the devices sending a reduced amount of energy to the heart during defibrillation. More than 7,000 devices are being recalled due to this issue.

Harvard researchers unlock the secret to building 3D-printed heart muscles that can beat

Creating these complex structures with 3D printing alone has never been possible—until now.

FDA announces recall of nearly 8,000 Impella blood pumps due to risk of injury or death in TAVR patients

There have been 30 complaints so far about this issue, including 26 injuries and four deaths.

Abbott recalls delivery sheath for LAA occluder device after 16 injuries

The FDA has categorized this as a Class I recall, which means using the devices “may cause serious injuries or death.”

More cardiology groups step forward with concerns about Medicare payment cuts

The CardioVascular Coalition and Society for Cardiovascular Angiography and Interventions have both issued new statements highlighting their issues with the 2024 MPFS proposed rule.

Clinical

Jury finds PeaceHealth, ER doctor not liable for misdiagnosing patient’s stroke

Women less likely to receive DCD heart transplants

Mayo Clinic develops AI capable of substantially improving dementia diagnoses

Private equity firm jumps into vascular health with new investment

At a crossroads: Surgical heart valve innovation slows as transcatheter treatments keep evolving